|
LOC440354 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.84109999970639E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.57460000000032E-06 |
| Normal-vs-Stage2 |
6.69169997191688E-09 |
| Normal-vs-Stage3 |
1.60439999952189E-07 |
| Normal-vs-Stage4 |
5.74700000033346E-07 |
| Stage1-vs-Stage2 |
2.860800E-03 |
| Stage1-vs-Stage3 |
8.676500E-02 |
| Stage1-vs-Stage4 |
1.150390E-01 |
| Stage2-vs-Stage3 |
2.212800E-01 |
| Stage2-vs-Stage4 |
4.537800E-01 |
| Stage3-vs-Stage4 |
7.891800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.36809999948551E-07 |
| Normal-vs-AfricanAmerican |
5.996400E-02 |
| Normal-vs-Asian |
4.029200E-04 |
| Caucasian-vs-AfricanAmerican |
1.263230E-01 |
| Caucasian-vs-Asian |
3.556600E-01 |
| AfricanAmerican-vs-Asian |
3.366200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.88929999983745E-07 |
| Normal-vs-Female |
4.34369999968709E-07 |
| Male-vs-Female |
6.278800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.99519999999342E-05 |
| Normal-vs-Age(41-60Yrs) |
1.3741000004508E-07 |
| Normal-vs-Age(61-80Yrs) |
1.51149999960687E-07 |
| Normal-vs-Age(81-100Yrs) |
1.727660E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.308400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.518500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.220000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.729400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.510600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.261600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.392420E-02 |
| Classical-VS-Follicular |
3.837600E-02 |
| Classical-VS-Other |
8.992200E-01 |
| Classical-VS-Normal |
4.23729999998734E-06 |
| Tall-VS-Follicular |
5.014600E-01 |
| Tall-VS-Other |
3.073400E-01 |
| Tall-VS-Normal |
6.85240000297682E-08 |
| Follicular-VS-Other |
5.887000E-01 |
| Follicular-VS-Normal |
1.47039999953691E-07 |
| Other-VS-Normal |
5.161600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60579999963772E-07 |
| Normal-vs-N1 |
1.56612999999695E-05 |
| N0-vs-N1 |
9.357000E-01 |
|
|
